Puma Biotechnology Statistics
Want to see PBYI full AI Analyst Report?
Puma Biotechnology (PBYI) Stock Statistics & Valuation Metrics
Total Valuation
Puma Biotechnology has a market cap or net worth of $368.09M. The enterprise value is $423.74M.
- Market Cap
- $368.09M
- Enterprise Value
- $423.74M
Share Statistics
Puma Biotechnology has 51,698,357 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 51,698,357
- Owned by Insiders
- 15.78%
- Owned by Institutions
- 62.69%
Financial Efficiency
Puma Biotechnology’s return on equity (ROE) is 0.24 and return on invested capital (ROIC) is 20.41%.
- Return on Equity (ROE)
- 0.24
- Return on Assets (ROA)
- 0.14
- Return on Invested Capital (ROIC)
- 20.41%
- Return on Capital Employed (ROCE)
- 0.28
- Revenue Per Employee
- 1.28M
- Profits Per Employee
- 173.80K
- Employee Count
- 179
- Asset Turnover
- 1.06
- Inventory Turnover
- 10.55
Valuation Ratios
The current PE Ratio of Puma Biotechnology is 14.95. Puma Biotechnology’s PEG ratio is -0.42.
- PE Ratio
- 14.95
- PS Ratio
- 1.59
- PB Ratio
- 2.51
- Price to FCF
- 7.99
- Price to Operating Cash Flow
- 7.98
- PEG Ratio
- -0.42
Income Statement
In the last 12 months, Puma Biotechnology had revenue of 228.37M and earned 31.11M in profits. Earnings per share was 0.62.
- Revenue
- 228.37M
- Gross Profit
- 170.21M
- Operating Income
- 37.30M
- Pretax Income
- 35.78M
- Net Income
- 31.11M
- EBITDA
- 53.34M
- Earnings Per Share (EPS)
- 0.62
Cash Flow
In the last 12 months, operating cash flow was 46.04M and capital expenditures 36,000, giving a free cash flow of 46.07M billion.
- Operating Cash Flow
- 46.04M
- Free Cash Flow
- 46.07M
- Free Cash Flow per Share
- 0.89
Dividends & Yields
Puma Biotechnology pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 12.51%
- Earnings Yield
- 6.48%
Stock Price Statistics
- Beta
- 1.17
- 52-Week Price Change
- 45.75%
- 50-Day Moving Average
- 9.66
- 200-Day Moving Average
- 8.06
- Relative Strength Index (RSI)
- 24.97
- Average Volume (3m)
- 379.16K
Important Dates
Puma Biotechnology upcoming earnings date is Mar 04, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 05, 2026
- Next Earnings Date
- Mar 04, 2027
- Ex-Dividend Date
- ―
Financial Position
Puma Biotechnology as a current ratio of 2.00, with Debt / Equity ratio of 21.90%
- Current Ratio
- 2.00
- Quick Ratio
- 1.93
- Debt to Market Cap
- 0.08
- Net Debt to EBITDA
- -0.02
- Interest Coverage Ratio
- 5.63
Taxes
In the past 12 months, Puma Biotechnology has paid 4.67M in taxes.
- Income Tax
- 4.67M
- Effective Tax Rate
- 0.13
Enterprise Valuation
Puma Biotechnology EV to EBITDA ratio is 8.22, with an EV/FCF ratio of 7.20.
- EV to Sales
- 1.43
- EV to EBITDA
- 8.22
- EV to Free Cash Flow
- 7.20
- EV to Operating Cash Flow
- 7.21
Balance Sheet
Puma Biotechnology has $108.50M in cash and marketable securities with $4.87M in debt, giving a net cash position of $103.63M billion.
- Cash & Marketable Securities
- $108.50M
- Total Debt
- $4.87M
- Net Cash
- $103.63M
- Net Cash Per Share
- $2.00
- Tangible Book Value Per Share
- $2.18
Margins
Gross margin is 73.59%, with operating margin of 11.27%, and net profit margin of 10.28%.
- Gross Margin
- 73.59%
- Operating Margin
- 11.27%
- Pretax Margin
- 12.12%
- Net Profit Margin
- 10.28%
- EBITDA Margin
- 17.40%
- EBIT Margin
- 13.00%
Analyst Forecast
The average price target for Puma Biotechnology is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 9.35%
- EPS Growth Forecast
- -37.15%
Scores
- Smart Score
- 7
- AI Score
- 61

